|
|
|
R E S O L U T I O N
|
|
WHEREAS, Since the onset of the COVID-19 pandemic, the Texas |
|
Tech University Health Sciences Center at Amarillo has played an |
|
integral role in the global campaign to advance understanding of |
|
the disease, to develop lifesaving treatments and therapies, and to |
|
provide essential medical care and vaccination services to the |
|
Amarillo community; and |
|
WHEREAS, In April 2020, TTUHSC was selected to be part of a |
|
U.S. government-sponsored, FDA-approved study conducted by Mayo |
|
Clinic to evaluate the use of convalescent plasma in treating |
|
patients with severe COVID-19; working in partnership with other |
|
institutions, the health sciences center swiftly mobilized to |
|
implement the project, and its participation provided patients in |
|
Amarillo with a treatment option that was difficult to attain at the |
|
time; and |
|
WHEREAS, Continuing to investigate the viability of new |
|
methods of treating COVID-19, TTUHSC entered into an agreement with |
|
Amarillo's PharmaTex Research to assist in a clinical trial of |
|
Regeneron's novel antiviral antibody cocktail in late summer of |
|
2020; at the time, the health sciences center was one of only 150 |
|
sites internationally and the only location in West Texas with |
|
access to the medications; and |
|
WHEREAS, In addition to facilitating studies and clinical |
|
trials, TTUHSC has helped increase Texas' testing capacity by |
|
producing viral transport media, a critical component of COVID-19 |
|
tests; at its peak, the health sciences center was generating |
|
between 15,000 and 20,000 vials of VTM per week, for a total of more |
|
than 450,000 vials, and the university went on to be recognized for |
|
its production of VTM in The Governor's Report to Open Texas |
|
publication issued by Governor Greg Abbott; the VTM project was led |
|
by a team from the TTUHSC Jerry H. Hodge School of Pharmacy and the |
|
School of Medicine, and the schools shared information about their |
|
effective methods with other universities and laboratories across |
|
the state; and |
|
WHEREAS, Another important initiative carried out by TTUHSC |
|
was the establishment of the Amarillo Center for Excellence for |
|
COVID-19 Research & Pandemics, which encompasses a range of efforts |
|
that are focused on the goal of predicting and preparing for future |
|
pandemics; special thanks is also owed to the many TTUHSC medical |
|
and pharmaceutical faculty members who have been on the front lines |
|
providing high-quality care to patients in area medical centers; in |
|
addition, the health sciences center has administered a total of |
|
more than 11,000 COVID-19 vaccinations on the Amarillo campus; and |
|
WHEREAS, The faculty, research staff, students, support |
|
staff, and administration of the Texas Tech University Health |
|
Sciences Center at Amarillo have lent their time, expertise, and |
|
resources to expedite critical research and treatment in the |
|
world's battle against COVID-19, and they are deserving of our |
|
lasting gratitude for their tireless dedication to this endeavor; |
|
now, therefore, be it |
|
RESOLVED, That the House of Representatives of the 87th Texas |
|
Legislature hereby commend the faculty, research staff, students, |
|
support staff, and administration of the Texas Tech University |
|
Health Sciences Center at Amarillo for their exceptional |
|
contributions in responding to the COVID-19 pandemic and extend to |
|
all those associated with the effort sincere best wishes for |
|
continued success in their important work; and, be it further |
|
RESOLVED, That an official copy of this resolution be |
|
prepared for the health sciences center as an expression of high |
|
regard by the Texas House of Representatives. |